Financhill
Back

Editas Medicine Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
3

EDIT
Editas Medicine

Last Price:
$1.27
Seasonality Move:
-5.52%
Buy
53

ALNY
Alnylam Pharmaceuticals

Last Price:
$273.40
Seasonality Move:
3.3%
Sell
3
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $1.30. The Score for EDIT is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
53
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $280.96. The Score for ALNY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $1.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $280.96
    The current trend is moderately bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.3 Buy
Relative Strength Index (14 RSI): 42.85 Sell
Chaikin Money Flow: -876975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.29 - 2.07) Sell
Bollinger Bands (100): (1.18 - 2.5) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.18 Buy
Relative Strength Index (14 RSI): 64.02 Buy
Chaikin Money Flow: -956276 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (237.98 - 264.74) Buy
Bollinger Bands (100): (240.44 - 271.42) Buy

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.37 Sell
20-day SMA: 1.59 Sell
50-day SMA: 1.48 Sell
200-day SMA: 3.09 Sell
8-day EMA: 0.85 Buy
20-day EMA: 0.44 Buy
50-day EMA: 0.2 Buy
200-day EMA: 0.05 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 262.64 Buy
20-day SMA: 251.27 Buy
50-day SMA: 258.44 Buy
200-day SMA: 252.16 Buy
8-day EMA: 267.69 Buy
20-day EMA: 258.45 Buy
50-day EMA: 256.39 Buy
200-day EMA: 243.81 Buy

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.12 per share, and an increase next year of $0.41 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):